Psychiatric and behavioral disorders in persons with Down syndrome

Topic: Health services, long-term care and technology

Similar to the state of the broader intellectual disabilities field, many gaps exist in the research and treatment of mental health concerns in people with Down syndrome. This review summarizes key findings on the type and prevalence of behavior and emotional problems in children, adolescents, and adults with Down syndrome. Such findings include relatively low rates of severe problems in children, and well-documented risks of depression and Alzheimer's disease in older adults. The review also considers emerging data on autism, and the paucity of studies on adolescents. Three next steps for research are highlighted, including a need to: (1) connect research on psychiatric status and diagnoses across developmental periods, including adolescence, and to examine such associated processes as sociability, anxiety and attention; (2) unravel complicated biopsycho-social risk and protective factors that serve to increase or diminish psychopathology; and (3) identify evidence-based treatments that both reduce distressful symptoms and enhance well-being in individuals with Down syndrome.

Key findings

• Similar to the state of the broader intellectual disabilities field, many gaps exist in the research and treatment of mental health concerns in people with Down syndrome.
• This review summarizes key findings on the type and prevalence of behavior and emotional problems in children, adolescents, and adults with Down syndrome.
• Such findings include relatively low rates of severe problems in children, and well-documented risks of depression and Alzheimer's disease in older adults.
• The review also considers emerging data on autism, and the paucity of studies on adolescents.
• Three next steps for research are highlighted, including a need to: (1) connect research on psychiatric status and diagnoses across developmental periods, including adolescence, and to examine such associated processes as sociability, anxiety and attention; (2) unravel complicated biopsycho-social risk and protective factors that serve to increase or diminish psychopathology; and (3) identify evidence-based treatments that both reduce distressful symptoms and enhance well-being in individuals with Down syndrome.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1002/mrdd.20159
• PubMed: 17910080
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{dykens2007-17910080,
  author  = {Dykens, E. M.},
  title   = {{Psychiatric and behavioral disorders in persons with Down syndrome}},
  journal = {Mental retardation and developmental disabilities research reviews},
  year    = {2007},
  doi     = {10.1002/mrdd.20159},
  pmid    = {17910080},
  url     = {https://doi.org/10.1002/mrdd.20159}
}

Related studies in Down syndrome and Alzheimer's

• Psychiatric disorders in persons with Down syndrome The Journal of nervous and mental disease · 1991-10-01 · usefulness score 48/100
• Patterns of depressive symptoms and social relating behaviors differ over time from other behavioral domains for young people with Down syndrome Medicine · 2015-05-01 · usefulness score 45/100
• Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model Biochemical pharmacology · 2012-08-08 · usefulness score 36/100
• Down syndrome: Cognitive and behavioral functioning across the lifespan American journal of medical genetics. Part C, Seminars in medical genetics · 2015-05-18 · usefulness score 36/100
• The effect of acetyl-L-carnitine administration on persons with Down syndrome Research in developmental disabilities · 2006-04-18 · usefulness score 49/100
• On chronological changes in the basic EEG rhythm in persons with Down syndrome - with special reference to slowing of alpha waves Brain & development · 2000-06-01 · usefulness score 43/100

Also tagged “dosage”

80 studies in the library carry the topic tag “dosage”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 80 tagged studies.

• Down syndrome and Alzheimer's disease: a link between development and aging Mental retardation and developmental disabilities research reviews · 2001-01-01 · usefulness score 41/100 · Down syndrome and Alzheimer's
• Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected] Nature genetics · 1993-09-01 · usefulness score 40/100 · Down syndrome and Alzheimer's

Similar studies

• Health care management of adults with Down syndrome 2001 · Risk factors
• Down's syndrome 2003 · Risk factors
• Sleep problems and associated comorbidities among adults with Down syndrome 2016 · Risk factors
• The importance of understanding individual differences in Down syndrome 2016 · Down syndrome and Alzheimer's
• Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records 2023 · Digital health tools
• A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome 2014 · Down syndrome and Alzheimer's

More on Down syndrome and Alzheimer's

• A review that covers this ground DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome Frontiers in behavioral neuroscience · 2016-06-03 · usefulness score 40/100
• Newest in this subject Differential endothelial cell remodeling in Down syndrome and APP duplication drives distinct blood brain barrier dysfunction bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Memory and Plasma pTau217 Refine Prognosis in Down Syndrome Annals of neurology · 2026-10-02 · Peer-reviewed · usefulness score 47/100

See all studies in Down syndrome and Alzheimer's →